Fusobacterium Nucleatum at Colorectal Cancer Sites
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05945082 |
Recruitment Status :
Recruiting
First Posted : July 14, 2023
Last Update Posted : July 14, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Colorectal Cancer Periodontitis | Other: biopsy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 150 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | Presence of Fusobacterium Nucleatum at Colorectal Cancer Sites - Influencing Factors and Screening Possibilities |
Actual Study Start Date : | November 29, 2017 |
Estimated Primary Completion Date : | December 31, 2025 |
Estimated Study Completion Date : | December 31, 2025 |
- Other: biopsy
biopsy of a colorectal cancer site
- Presence of F.nucleatum in a colon cancer biopsy [ Time Frame: At timepoint of biopsy ]dichotomous (present / absent)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 120 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- diagnosis of colorectal cancer
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05945082
Contact: Kristina Bertl | 00436645151194 | kristina.bertl@mau.se | |
Contact: Andreas Stavropoulos | andreas.stavropoulos@mau.se |
Sweden | |
Skane University Hospital | Recruiting |
Malmö, Sweden | |
Contact: Klas Sjöberg |
Responsible Party: | Malmö University |
ClinicalTrials.gov Identifier: | NCT05945082 |
Other Study ID Numbers: |
Dnr 2016/469 |
First Posted: | July 14, 2023 Key Record Dates |
Last Update Posted: | July 14, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Colorectal Neoplasms Periodontitis Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms Digestive System Diseases |
Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Periodontal Diseases Mouth Diseases Stomatognathic Diseases |